Learn More
Description
Profilin-1 (PFN1) plays an important role in the control of actin dynamics, and could represent an important therapeutic target in several diseases. PFN1 is identified as a huntingtin aggregation inhibitor, and may serves as a tumor-suppressor. PFN1 is crucial for the conversion of monomeric (G)-actin to filamentous (F)-actin. Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disorder resulting from motor neuron death. Cells expressing PFN1 mutants contain ubiquitinated, insoluble aggregates that in many cases contain the ALS-associated protein TDP-43. Recently, PFN1 is a potential biomarker for bladder cancer aggressiveness and may be of great clinical importance.
Specifications
Specifications
| Antigen | PFN1 |
| Applications | Immunofluorescence |
| Classification | Monoclonal |
| Clone | 3A12E8 |
| Concentration | 991 μg/mL |
| Conjugate | CoraLite 594 |
| Host Species | Mouse |
| Quantity | 100 μL |
| Primary or Secondary | Primary |
| Gene ID (Entrez) | 5216 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.